Abstract
Congenital heart defects (CHD) are the most prevalent anomaly both clinically and in laboratory animal species. Historically, it was difficult to assess the longitudinal progression or repair of such anomalies because assessment methodologies were too invasive (gross exams and/or histology). Recently, technological advances in the field of diagnostic imaging have led to the manufacture of high-resolution ultrasound (HRUS), capable of characterizing both embryonic and maternal cardiovascular structure and function in small animals (rat and mouse). HRUS is relatively noninvasive, facilitating the longitudinal assessment of heart development throughout gestation and postnatally, providing a comprehensive evaluation of changes in cardiovascular performance following toxicant exposure.
Described herein is a brief overview of important theoretical and practical considerations when applying HRUS to understand the impact of perturbations on the fetal heart. Examples are given from our own work to help the reader interpret their own HRUS images and more readily identify anomalies in utero. In addition to embryonic assessment, maternal pathologies may adversely affect the cardiovascular performance of the conceptus indirectly. Umbilical blood flow is particularly vulnerable to such effects and procedures to assess this endpoint are described. Neonatal rats, born with CHD, may respond pathologically to cardiovascular challenges as they mature, and we outline the use of HRUS to evaluate cardiac performance over the lifetime of the animal. Some of the caveats related to HRUS are discussed, particularly with the emphasis on how this may impact experimental design.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900
Purssell E, Weston AD, Thomson JJ et al (2012) Noninvasive high-resolution ultrasound reveals structural and functional deficits in dimethadione-exposed fetal rat hearts in utero. Birth Defects Res B Dev Reprod Toxicol 95:35–46. https://doi.org/10.1002/bdrb.20339
Albaghdadi AJH, Hewitt MA, Putos SM et al (2017) Tacrolimus in the prevention of adverse pregnancy outcomes and diabetes-associated embryopathies in obese and diabetic mice. J Transl Med 15:32. https://doi.org/10.1186/s12967-017-1137-4
Fleeman TL, Cappon GD, Hurtt ME (2004) Postnatal closure of membranous ventricular septal defects in Sprague-Dawley rat pups after maternal exposure with trimethadione. Birth Defects Res B Dev Reprod Toxicol 71:185–190. https://doi.org/10.1002/bdrb.20011
Solomon HM, Wier PJ, Fish CJ et al (1997) Spontaneous and induced alterations in the cardiac membranous ventricular septum of fetal, weanling, and adult rats. Teratology 55:185–194
Aasa KL, Maciver RD, Ramchandani S et al (2015) In utero exposure to a cardiac teratogen causes reversible deficits in postnatal cardiovascular function, but altered adaptation to the burden of pregnancy. Toxicol Sci 148:155–166. https://doi.org/10.1093/toxsci/kfv169
Aasa KL, Purssell E, Adams MA, Ozolinš TRS (2014) In utero dimethadione exposure causes postnatal disruption in cardiac structure and function in the rat. Toxicol Sci 142:350–360. https://doi.org/10.1093/toxsci/kfu190
Yin FC, Spurgeon HA, Rakusan K et al (1982) Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol 243:H941–H947. https://doi.org/10.1152/ajpheart.1982.243.6.H941
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Maciver, R.D., Ozolinš, T.R.S. (2019). The Application of High-Resolution Ultrasound for Assessment of Cardiac Structure and Function Associated with Developmental Toxicity. In: Hansen, J., Winn, L. (eds) Developmental Toxicology. Methods in Molecular Biology, vol 1965. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9182-2_26
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9182-2_26
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9181-5
Online ISBN: 978-1-4939-9182-2
eBook Packages: Springer Protocols